Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 23 | $16,112,140 |
Sells | 54 | $7,669,486 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
10 Sep 2024 20:31 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | CHIEF EXECUTIVE OFFICER | 09 Sep 2024 | Sale | 7,352 | 12.1901 | 89,622 | D |
26 Aug 2024 20:00 | KALV | KalVista Pharmaceuticals Inc | AUDHYA PAUL K. | CHIEF MEDICAL OFFICER | 23 Aug 2024 | Sale | 2,135 | 12.4 | 26,474 | D |
26 Aug 2024 19:58 | KALV | KalVista Pharmaceuticals Inc | YEA CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | 23 Aug 2024 | Sale | 1,916 | 12.4 | 23,758 | D |
21 Aug 2024 21:26 | KALV | KalVista Pharmaceuticals Inc | AUDHYA PAUL K. | CHIEF MEDICAL OFFICER | 19 Aug 2024 | Sale | 7,973 | 12.0133 | 95,782 | D |
21 Aug 2024 21:25 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | CHIEF EXECUTIVE OFFICER | 19 Aug 2024 | Sale | 14,215 | 12.0133 | 170,769 | D |
21 Aug 2024 21:25 | KALV | KalVista Pharmaceuticals Inc | YEA CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | 19 Aug 2024 | Sale | 7,102 | 12.0133 | 85,318 | D |
10 Jun 2024 18:42 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | CHIEF EXECUTIVE OFFICER | 07 Jun 2024 | Sale | 7,465 | 11.5296 | 86,068 | D |
21 May 2024 17:59 | KALV | KalVista Pharmaceuticals Inc | FEENER EDWARD P. | CHIEF SCIENTIFIC OFFICER | 20 May 2024 | Sale | 8,088 | 11.7645 | 95,151 | D |
21 May 2024 17:58 | KALV | KalVista Pharmaceuticals Inc | AUDHYA PAUL K. | CHIEF MEDICAL OFFICER | 20 May 2024 | Sale | 13,175 | 11.7645 | 154,997 | D |
21 May 2024 17:57 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | CHIEF EXECUTIVE OFFICER | 20 May 2024 | Sale | 21,959 | 11.7645 | 258,337 | D |
21 May 2024 17:55 | KALV | KalVista Pharmaceuticals Inc | YEA CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | 20 May 2024 | Sale | 11,610 | 11.7645 | 136,586 | D |
21 Feb 2024 21:51 | KALV | KalVista Pharmaceuticals Inc | FEENER EDWARD P. | CHIEF SCIENTIFIC OFFICER | 20 Feb 2024 | Sale | 300 | 14.72 | 4,416 | D |
21 Feb 2024 21:51 | KALV | KalVista Pharmaceuticals Inc | FEENER EDWARD P. | CHIEF SCIENTIFIC OFFICER | 20 Feb 2024 | Sale | 19,591 | 14.0366 | 274,991 | D |
21 Feb 2024 21:51 | KALV | KalVista Pharmaceuticals Inc | FEENER EDWARD P. | CHIEF SCIENTIFIC OFFICER | 20 Feb 2024 | Sale | 8,397 | 14.1148 | 118,522 | D |
21 Feb 2024 21:48 | KALV | KalVista Pharmaceuticals Inc | YEA CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | 20 Feb 2024 | Sale | 12,053 | 14.1147 | 170,124 | D |
21 Feb 2024 21:46 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | CFO, CBO | 20 Feb 2024 | Sale | 22,802 | 14.1148 | 321,846 | D |
21 Feb 2024 21:44 | KALV | KalVista Pharmaceuticals Inc | AUDHYA PAUL K. | CHIEF MEDICAL OFFICER | 20 Feb 2024 | Sale | 14,295 | 14.115 | 201,774 | D |
21 Feb 2024 21:41 | KALV | KalVista Pharmaceuticals Inc | CROCKETT THOMAS ANDREW | CEO | 20 Feb 2024 | Sale | 24,888 | 14.1148 | 351,289 | D |
16 Feb 2024 16:21 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | CFO, CBO | 14 Feb 2024 | Sale | 40,855 | 15.0093 | 613,205 | D |
16 Feb 2024 16:20 | KALV | KalVista Pharmaceuticals Inc | CROCKETT THOMAS ANDREW | CEO | 14 Feb 2024 | Sale | 58,356 | 15.0093 | 875,883 | D |
16 Feb 2024 16:19 | KALV | KalVista Pharmaceuticals Inc | FEENER EDWARD P. | CHIEF SCIENTIFIC OFFICER | 14 Feb 2024 | Sale | 28,171 | 15.0093 | 422,827 | D |
16 Feb 2024 16:18 | KALV | KalVista Pharmaceuticals Inc | YEA CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | 14 Feb 2024 | Sale | 39,886 | 15.0093 | 598,661 | D |
08 Feb 2024 20:11 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 08 Feb 2024 | Purchase | 29,747 | 14.7 | 437,281 | I |
08 Feb 2024 20:11 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 07 Feb 2024 | Purchase | 51,827 | 14.56 | 754,601 | I |
08 Feb 2024 20:11 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 06 Feb 2024 | Purchase | 4,474 | 14.74 | 65,947 | I |
05 Feb 2024 17:55 | KALV | KalVista Pharmaceuticals Inc | CROCKETT THOMAS ANDREW | CEO | 01 Feb 2024 | Sale | 700 | 16.8143 | 11,770 | D |
05 Feb 2024 17:55 | KALV | KalVista Pharmaceuticals Inc | CROCKETT THOMAS ANDREW | CEO | 01 Feb 2024 | Sale | 9,300 | 16.1751 | 150,428 | D |
01 Feb 2024 16:38 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 30 Jan 2024 | Purchase | 88,099 | 14.47 | 1,274,793 | I |
29 Jan 2024 19:07 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 29 Jan 2024 | Purchase | 80,600 | 14.22 | 1,146,132 | I |
29 Jan 2024 19:07 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 26 Jan 2024 | Purchase | 4,174 | 12.98 | 54,179 | I |
29 Jan 2024 19:07 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 25 Jan 2024 | Purchase | 7,030 | 12.73 | 89,492 | I |
24 Jan 2024 20:24 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 24 Jan 2024 | Purchase | 20,686 | 12.44 | 257,334 | I |
24 Jan 2024 20:24 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 23 Jan 2024 | Purchase | 10,897 | 12.54 | 136,648 | I |
24 Jan 2024 20:24 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 22 Jan 2024 | Purchase | 67,546 | 12.55 | 847,702 | I |
19 Jan 2024 18:02 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 19 Jan 2024 | Purchase | 25,000 | 12.43 | 310,750 | I |
19 Jan 2024 18:02 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 17 Jan 2024 | Purchase | 78,925 | 12.6 | 994,455 | I |
19 Jan 2024 18:02 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 18 Jan 2024 | Purchase | 39,680 | 12.51 | 496,397 | I |
16 Jan 2024 19:04 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 16 Jan 2024 | Purchase | 19,599 | 12.73 | 249,495 | I |
16 Jan 2024 19:04 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 11 Jan 2024 | Purchase | 6,647 | 12.68 | 84,284 | I |
12 Jan 2024 16:26 | KALV | KalVista Pharmaceuticals Inc | FEENER EDWARD P. | Chief Scientific Officer | 11 Jan 2024 | Sale | 22,679 | 13.0303 | 295,514 | D |
10 Jan 2024 20:57 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 10 Jan 2024 | Purchase | 47,700 | 12.67 | 604,359 | I |
10 Jan 2024 20:57 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 09 Jan 2024 | Purchase | 20,816 | 12.56 | 261,449 | I |
10 Jan 2024 20:57 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 08 Jan 2024 | Purchase | 69,184 | 12.44 | 860,649 | I |
10 Jan 2024 18:05 | KALV | KalVista Pharmaceuticals Inc | FEENER EDWARD P. | Chief Scientific Officer | 08 Jan 2024 | Sale | 17,221 | 13.0074 | 224,000 | D |
10 Jan 2024 18:05 | KALV | KalVista Pharmaceuticals Inc | FEENER EDWARD P. | Chief Scientific Officer | 09 Jan 2024 | Sale | 100 | 13 | 1,300 | D |
05 Jan 2024 16:13 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 04 Jan 2024 | Purchase | 41,764 | 12.11 | 505,762 | I |
05 Jan 2024 16:13 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 03 Jan 2024 | Purchase | 17,605 | 12.2 | 214,781 | I |
29 Dec 2023 18:44 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 29 Dec 2023 | Purchase | 6,013 | 12.49 | 75,102 | I |
29 Dec 2023 18:44 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 28 Dec 2023 | Purchase | 471,490 | 12.5 | 5,893,625 | I |
29 Dec 2023 18:44 | KALV | KalVista Pharmaceuticals Inc | VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% | 27 Dec 2023 | Purchase | 41,514 | 11.97 | 496,923 | I |
28 Dec 2023 16:28 | KALV | KalVista Pharmaceuticals Inc | CROCKETT THOMAS ANDREW | CEO | 27 Dec 2023 | Sale | 30,000 | 12.0151 | 360,453 | D |
21 Nov 2023 16:34 | KALV | KalVista Pharmaceuticals Inc | AUDHYA PAUL K. | Chief Medical Officer | 20 Nov 2023 | Sale | 7,985 | 8.2293 | 65,711 | D |
21 Nov 2023 16:33 | KALV | KalVista Pharmaceuticals Inc | FEENER EDWARD P. | Chief Scientific Officer | 20 Nov 2023 | Sale | 4,958 | 8.2293 | 40,801 | D |
21 Nov 2023 16:32 | KALV | KalVista Pharmaceuticals Inc | YEA CHRISTOPHER | Chief Development Officer | 20 Nov 2023 | Sale | 7,113 | 8.2293 | 58,535 | D |
21 Nov 2023 16:31 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | President, CFO, CBO & Sec'y | 20 Nov 2023 | Sale | 13,008 | 8.2293 | 107,047 | D |
21 Nov 2023 16:30 | KALV | KalVista Pharmaceuticals Inc | CROCKETT THOMAS ANDREW | CEO | 20 Nov 2023 | Sale | 14,807 | 8.2293 | 121,851 | D |
13 Sep 2023 16:29 | KALV | KalVista Pharmaceuticals Inc | CHA ALBERT | Director | 11 Sep 2023 | Sale | 18,000 | 10.5028 | 189,050 | D |
21 Aug 2023 20:09 | KALV | KalVista Pharmaceuticals Inc | AUDHYA PAUL K. | Chief Medical Officer | 18 Aug 2023 | Sale | 8,020 | 10.7288 | 86,045 | D |
21 Aug 2023 20:07 | KALV | KalVista Pharmaceuticals Inc | FEENER EDWARD P. | Chief Scientific Officer | 18 Aug 2023 | Sale | 4,976 | 10.7287 | 53,386 | D |
21 Aug 2023 20:06 | KALV | KalVista Pharmaceuticals Inc | YEA CHRISTOPHER | Chief Development Officer | 18 Aug 2023 | Sale | 7,142 | 10.7287 | 76,624 | D |
21 Aug 2023 20:05 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | President, CFO, CBO & Sec'y | 18 Aug 2023 | Sale | 13,067 | 10.7287 | 140,192 | D |
21 Aug 2023 20:05 | KALV | KalVista Pharmaceuticals Inc | CROCKETT THOMAS ANDREW | CEO | 18 Aug 2023 | Sale | 14,876 | 10.7288 | 159,602 | D |
19 May 2023 21:20 | KALV | KalVista Pharmaceuticals Inc | YEA CHRISTOPHER | Chief Development Officer | 18 May 2023 | Sale | 2,604 | 10.1444 | 26,416 | D |
19 May 2023 21:19 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | President, CFO, CBO & Sec'y | 18 May 2023 | Sale | 4,037 | 10.1444 | 40,953 | D |
19 May 2023 21:18 | KALV | KalVista Pharmaceuticals Inc | FEENER EDWARD P. | Chief Scientific Officer | 18 May 2023 | Sale | 1,786 | 10.1444 | 18,118 | D |
19 May 2023 21:17 | KALV | KalVista Pharmaceuticals Inc | CROCKETT THOMAS ANDREW | CEO | 18 May 2023 | Sale | 5,627 | 10.1444 | 57,083 | D |
19 May 2023 21:16 | KALV | KalVista Pharmaceuticals Inc | AUDHYA PAUL K. | Chief Medical Officer | 18 May 2023 | Sale | 2,780 | 10.1444 | 28,201 | D |
23 Feb 2023 17:44 | KALV | KalVista Pharmaceuticals Inc | AUDHYA PAUL K. | Chief Medical Officer | 17 Feb 2023 | Sale | 3,412 | 7.66 | 26,136 | D |
23 Feb 2023 17:44 | KALV | KalVista Pharmaceuticals Inc | FEENER EDWARD P. | Chief Scientific Officer | 17 Feb 2023 | Sale | 2,228 | 7.66 | 17,066 | D |
23 Feb 2023 17:42 | KALV | KalVista Pharmaceuticals Inc | YEA CHRISTOPHER | Chief Development Officer | 17 Feb 2023 | Sale | 2,727 | 7.66 | 20,889 | D |
23 Feb 2023 17:41 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | President, CFO, CBO & Sec'y | 17 Feb 2023 | Sale | 4,954 | 7.66 | 37,948 | D |
23 Feb 2023 17:40 | KALV | KalVista Pharmaceuticals Inc | CROCKETT THOMAS ANDREW | CEO | 17 Feb 2023 | Sale | 6,700 | 7.66 | 51,322 | D |
21 Nov 2022 16:21 | KALV | KalVista Pharmaceuticals Inc | YEA CHRISTOPHER | Chief Development Officer | 18 Nov 2022 | Sale | 1,139 | 5.44 | 6,196 | D |
21 Nov 2022 16:20 | KALV | KalVista Pharmaceuticals Inc | PALLEIKO BENJAMIN L | CFO, CBO & Secretary | 18 Nov 2022 | Sale | 722 | 5.44 | 3,928 | D |
21 Nov 2022 16:18 | KALV | KalVista Pharmaceuticals Inc | FEENER EDWARD P. | Chief Scientific Officer | 18 Nov 2022 | Sale | 530 | 5.44 | 2,883 | D |
21 Nov 2022 16:17 | KALV | KalVista Pharmaceuticals Inc | CROCKETT THOMAS ANDREW | CEO | 18 Nov 2022 | Sale | 1,785 | 5.44 | 9,710 | D |
21 Nov 2022 16:15 | KALV | KalVista Pharmaceuticals Inc | AUDHYA PAUL K. | Chief Medical Officer | 18 Nov 2022 | Sale | 722 | 5.44 | 3,928 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)